Clinical Trial Update: Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)

View source ↗

Summary

A clinical trial is studying the safety of aflibercept injection in Japanese patients with neovascular glaucoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Glaucoma

Drugs mentioned

• aflibercept injection (aflibercept)

Snippet

Sponsor: Bayer | Conditions: Neovascular Glaucoma | Status: RECRUITING